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1. ABSTRACT 
 
Non alcoholic fatty liver disease (NAFLD) is 
associated with obesity, diabetes and insulin resistance 
(IR). The aim of our study was to assess the relationship 
between IR, anthropometry, lifestyle habits, resting energy 
expenditure (REE) and degree of fatty liver at ultrasound in 
48 overweight patients with NAFLD as compared to 24 
controls without fatty liver, matched for age. Nutritional 
status, alcohol intake and physical activity were assessed 
by skinfold thickness measurements, a 7-day diary, and 
SenseWear armband (SWA). REE was assessed by both 
SWA (REE-SWA) and a Vmax metabolic cart (REE-
Vmax). Fatty liver was measured by US and the Doppler 
Power Index was calculated. IR was assessed using the 
HOMA index. There was significant correlation between 
waist circumference, HOMA, Doppler power index and 
fatty liver grade at US. Multivariate analysis showed that 
alteration of waist circumference, Doppler power index, 
and HOMA were the major significant predictors of  fatty 
liver. Our data demonstrated a significant association 
between NAFLD and central adiposity and IR. 
 
 
 
 
 
 
 
 
 
2. INTRODUCTION 
 
 Non alcoholic fatty liver disease (NAFLD) has 
been found to be the most prevalent chronic liver disease in 
Western countries (1-3), it is closely associated with the 
presence of insulin resistance (IR), and is now considered 
the early hepatic manifestation of metabolic syndrome  (3, 
4). NAFLD encompasses a histological spectrum ranging 
from simple steatosis to non-alcoholic steatohepatitis 
(NASH), advanced fibrosis, and cirrhosis (5), its 
histological features resembles those of alcoholic 
steatohepatitis, however it occurs in patients who consume 
less than 20 g of alcohol per day (6).  Liver biopsy still 
remains the gold-standard and most cost-effective test in 
patients with NAFLD for the diagnosis of NASH, but not 
for diagnosis of NAFLD itself (7), which is usually 
formulated, particularly in general  population studies, with 
liver ultrasound. The benefits of changes in lifestyle habits 
in NAFLD, meaning gradual weight loss, increase in 
physical activity, and behaviour therapy, are fairly well 
established as the first choice treatment for NAFLD (8-11). 
However systematic and complete analysis of the possible 
differences in eating habits, physical activity, 
anthropometric measurements, body composition, energy 
expenditure, and IR between overweight patients with and 
without NAFLD are lacking. 
 
The aim of this study was to evaluate the possible 
correlation between the presence of fatty liver, diagnosed 
by the non-invasive method of liver ultrasound, with diet, 
energy expenditure, body composition, physical activity 
and IR, as detected by the homeostasis model assessment 
(HOMA) index, in overweight adult patients with NAFLD 
as compared to controls. 
 
3. MATERIAL AND METHODS 
 
3.1. Subjects 
 A convenience sample of 72 subjects: 48 patients 
with NAFLD (29 males and 19 females), and 24 apparently 
healthy controls without NAFLD (14 males and 10 females), 
matched for age, but not for body mass index (BMI), since this 
could be one of the predictors of NAFLD, were enrolled in the 
study.  
 
Subjects were asked to follow their usual diet during 
the week preceding the study. Each subject underwent a 
general history and physical examination, an anthropometric 
assessment,  a dietary and daily physical activity evaluation, a 
clinical and laboratory evaluation, and a liver ultrasound. The 
diagnosis of FL was performed by ultrasound, using 
standardised criteria (12) , and the amount of fat in the liver 
was graded from 1 to 4 on the basis of the presence of 1 or 
more of the following signs: a) Poor visibility of intrahepatic 
venous vessels and no expansion of the hepatic and portal 
veins diameters at deep breath; b) Diffuse hyperechoic 
echotexture (“bright liver”); c) Deep echo attenuation; d) 
Increased liver echotexture compared with the kidney.  Liver 
ultrasound was performed in all subjects by the same operator, 
who was unaware of the clinical and laboratory data. NAFLD 
was operationally defined as the presence of fatty liver in a 
subject drinking no more than 20 g/day of ethanol, in the 
absence of both HBsAg and HCV-RNA positivity (13). Any 
patients with other medical illnesses or other causes of chronic 
or acute liver disease were excluded from the study. Clinical 
examination included a detailed interview aimed at excluding 
the use, in the last 6 months, of drugs able to induce fatty liver 
(e.g., amiodarone, anti-oestrogen receptors), surgical 
procedures able to induce fatty liver (e.g., bilio-pancreatic 
diversion) or the presence of other significant steatosis-
inducing condition, such as hypothyroidism or polycystic 
ovary syndrome. Systolic and diastolic blood pressure was 
measured in triplicate on the same day, and the mean value of 
the three measurements was used for analysis(14).  
 
The study was conducted according to the 
guidelines established by the Declaration of Helsinki and 
all procedures involving human subjects/patients were 
approved by the local ethics committee. Written informed 
consent was obtained from all subjects.  
 
3.2. Laboratory tests 
Laboratory evaluation included HBsAg and anti-
HCV antibodies, measured as described elsewhere (15). 
Alanine transaminase (ALT), gamma-glutamyl transferase 
(GGT), fasting glucose, triglycerides, cholesterol and high-
density lipoprotein (HDL) cholesterol, were performed 
using standard laboratory methods. Insulin was measured 
by radioimmunoassay (ADVIA Insulin Ready Pack 100, 
Bayer Diagnostics, Milan, Italy), with intra- and inter-assay 
coefficients of variation 5%, and insulin sensitivity was 
estimated using the HOMA method ([glucose (mmol/L) / 
insulin (mU/L)]/22.5)(16).  
 
3.3. Anthropometry 
All anthropometric measurements were 
performed by the same operator according to the 
Anthropometric Standardization Reference Manual (17). 
Skinfold thicknesses (biceps, triceps, sub-scapular, supra-
iliac, calf and mid-thigh) and circumferences (arm, waist, 
hip, calf and mid-thigh) were measured to the nearest 
millimetre using callipers on the right-hand side of the 
body and an anthropometric tape, respectively (Holtain, 
Crymich, UK) (17). All skinfold and circumference 
measurements were repeated three times and the three 
values were averaged. Weight (Wt) was measured to the 
nearest 100 g and height (Ht) to the nearest 0.1 cm using an 
electronic scale with a built-in stadiometer (Tanita, Tokyo, 
Japan). Body mass index (BMI) was calculated as Wt/Ht2 
(kg/m2).  
  
3.4. Resting energy expenditure (REE) measurement. 
REE was measured in the morning 
(08:00e10:00am), using both Sense Wear Armband (SWA - 
SenseWear Pro2 Armband, BodyMedia Inc, Pittsburgh, 
PA, USA) and ) and a Sensor Medics Vmax metabolic cart 
with a ventilated canopy  (SM-29N Metabolic Cart, Yorbe 
Linda CA, USA), after a 12 h fast and at least 24 h free of 
structured PA on different days of the same week (18).  The 
SWA is a portable device that monitors various 
physiological parameters (heat flux, skin temperature, 
galvanic skin response and near-body temperature), 
demographic characteristics (gender, age, height, weight), 
introduced into proprietary algorithms to estimate energy 
expenditure, and movement (accelerometer). SWA has 
already undergone validation studies in different fields (19, 
20) and has been shown to be not completely reliable for 
the assessment of REE (20), but very useful for the 
assessment of physical movement and lifestyles (21, 22).  
 
The SWA was positioned in all patients over the 
triceps muscle on the upper right arm, halfway between the 
acromion and olecranon processes, 10 min before data 
collection (23). SWA data were collected for at least 3 
work days. REE- SWA was estimated by the Innerview 
Research Software version 6.0.  
 
All measurements with the ventilated canopy and 
the SM-29N Metabolic Cart were made in a thermoneutral 
environment and in the absence of external stimuli. All the 
subjects were asked to rest quietly in a supine position for 
approximately 30 or 40 min in an isolated room, with a 
temperature of between 20 and 25°C, after which REE 
measurements were performed with subjects remaining in 
the supine position. The data collected during the first 5-10 
min were discarded to allow the subjects to adapt to the 
canopy and instrument noise (24). The criterion for a valid 
REE was 15 min of steady state, determined as <5% 
variation in respiratory quotient (RQ)/minute and oxygen 
consumption/minute. At least 30 min of respiratory gas 
exchange data were collected. Oxygen consumption and 
carbon dioxide production were used to calculate REE in 
accordance with the Weir formula (25). 
 
3.5. Dietary assessment 
A simple 7-day diary of food intake exploring time, type 
and quantity of all the food and beverage (enclosed 
water) eaten and drunk was explained and administered 
to the subjects by a trained dietician, who discussed it 
with the subject when he or she handed it in one week 
later. To avoid the possible confounding effect of 
seasonality on food intake, the 7-day diary was 
administered to a similar number of cases and controls each 
month. Mean daily ethanol intake was calculated as the 
mean value of ethanol intake as assessed by the 7-day 
diary, which is the recognized gold standard for the 
assessment of food intake (16) and is more accurate than 
conventional methods for the evaluation of alcohol intake 
(26).  
 
3.6. Physical activity evaluation 
Physical activity was measured by using both a 
standardized physical exercise diary (27), and the SWA 
mentioned above. Both the diary and SWA measurements 
were expressed in metabolic equivalent. One metabolic 
equivalent is defined as the amount of oxygen consumed 
while sitting at rest and is equal to 3.5 ml O2 per kg body 
weight x min. The metabolic equivalent concept represents 
a simple, practical, and easily understood procedure for 
expressing the energy cost of physical activity as a multiple 
of the resting metabolic rate. The energy cost of an activity 
can be determined by dividing the relative oxygen cost of 
the activity (ml O2/kg/min) x by 3.5 (28). 
 
3.7. Power Doppler measurements 
Doppler Perfusion Index (DPI) was measured as 
suggested by Kakkos SK and coworkers (29). Briefly, for 
performing liver and Doppler ultrasound we used a Colour 
Doppler Ultrasound machine and a 3-MHz Convex array 
transducer (Esaote, Italy). The instrument was used with 
the proper software for direct and automatic calculation of 
haemodynamic parameters based on the spectral Doppler 
waveform. 
 
The following haemodynamic indices were measured at the 
portal vein and the common hepatic artery: 
 
1. Time averaged mean velocity (mean TAV); 
2. Portal vein and hepatic artery flow volume (PFV, HFV)   
[Vessel Cross Section x mean TAV]; 
3. Doppler perfusion index (DPI) [HFV/PFV + HFV] 
 
Patients were fasting and had not taken any 
medication for at least 12 h prior to the examination. Portal 
vein measurements were taken in a supine position right at 
the origin of the vessel from the splenic and superior 
mesenteric veins. Hepatic artery measurements were also 
taken right at the origin of the vessel from the coeliac trunk. 
All patients were asked to hold their breath briefly. We 
recorded the Doppler waveforms for at least four cardiac 
cycles. The size of the volume sample was equal to the 
vessel diameter in all cases. The angle between the beam 
and the vessel was always less than  60° and the vessel 
diameter was always measured at the sampling point. 
 
All portal vein and common hepatic artery 
measurements for each individual were obtained at least 
three times and the average values were entered in the 
calculation of the DPI. All the measurements were taken by 
the same expert operator (L.M.). The intra-observer 
variability in the obese patients was similar to that with 
normal controls. 
 
3.8. Statistical analysis 
 Continuous variables are given as medians and 
interquartile ranges on account of  skewed distributions. 
Comparisons of continuous variables between subjects with 
and without  NAFLD were performed with the Mann-
Whitney U test and those of nominal variables with 
Fisher’s exact test. The analysis of risk factors for NAFLD 
was performed in the pooled sample by comparing subjects 
with NAFLD with those with normal liver (controls). 
Comparisons of continuous variables between subjects with 
NAFLD, and normal liver were performed with the 
Kruskal-Wallis H test and those of nominal variables with 
Pearson’s chi-square test.  
 
Pearson and Spearman correlations were used to 
evaluate the relationship between REE-SWA and REE-
Vmax, and between fat mass percentage and fat-free mass 
percentage with different body composition methods. 
Bland and Altman’s method was also used to calculate the 
limits of agreement between REE-SWA and REE-Vmax 
(30). Bias was defined as the difference between REE-
SWA and REE-Vmax . Pitman’s test was used to evaluate 
proportional bias (30). Lin’s concordance correlation 
coefficient  was calculated as a further measure of 
agreement (31). 
 
Predictors or risk factors for the presence of 
NAFDL were evaluated with a multinomial logistic 
regression model, and the Cochran Mantel-Haenszel 
likelihood ratio test was used to assess overall significance 
(32).  Odds ratios (OR) and 95% confidence intervals (C.I.) 
were calculated. Significant predictors of the presence of 
NAFLD at univariate analysis were evaluated at 
multivariate analysis. The cut-offs for all the variables used 
were based on the upper limit of the median value found in 
the control group and reported in Table 1, and the Wald test 
statistic was used to assess overall significance. Statistical 
significance for all the tests was set as p values less than 
0.05. Statistical analysis was performed using SPSS for 
windows version 14.0 (SPSS Inc., Chicago, Illinois, USA). 
 
4. RESULTS 
 
4.1. Characteristics of subjects with and without 
NAFLD 
 As reported in Table 1, the only parameters found 
to be significantly different in both sexes in patients with
 
 
Table 1. Baseline characteristic of the population studied with and without NAFLD 
 Controls  (n=24) NAFLD (n=48) P (NAFLD vs Controls) 
 M (14)            F(10) M (29)        F(19) M             F 
Age (years) 60(21)          59(18) 51(21)        58(19) N.S.           N.S. 
Weight (kg) 74.25(13.8)   65.0(15) 82.5(19.5)     77(19.5) 0.016          0.007 
Stature (cm) 174(9)        160(14) 171 (12)      157(8) N.S.           N.S. 
BMI 24.9(4.8)   25.5(6.1) 29.4(4.4)      32.8(7.1) 0.001          0.004 
Sistolic BP (mmHg) 130(10)      130(10) 130(15)      135(15)     N.S.           N.S. 
Diastolic BP (mmHg) 80(10)       85(5) 80(5)        85(10) N.S.           N.S. 
Glicemia (mg/dl) 106(9)        93(6) 103(16)     97(20) N.S.           N.S. 
ALT (UI/l) 23(10)       19(7) 41(24)        22(13) 0.008          N.S. 
Gamma-GT (UI/l) 21(14)       15(18) 32(15)        22(13) 0.008          N.S. 
Insulinemia (ng/ml) 4.0(4)        5.3(3.4) 8.3(5.6)      8.5(3.8) 0.010         0.008 
HOMA 0.9(1.1)      1.2(0.8) 2.15(1.4)      2.13(1.7) 0.008         0.002 
Tryglicerides (mg/dl) 72(39)       87(44) 132(73)    110(103) 0.011          N.S. 
HDL-Cholesterol (mg/dl) 49(18)      54(26) 42(19)        51(12) N.S.           N.S. 
Doppler Power Index (DPI) 0.13(0.05)  0.18(0.04) 0.20(0.08)     0.20(0.08) 0.001         0.020 
Phys. Act (MET-SW ArmBand) 1.4(0.3)       1.4(0.7) 1.4(0.4)     1.2(0.5) N.S.           N.S. 
Physical Activity (MET Diary) 1.2(0.6)      1.0(0,3) 1.3(0.4)     1.0(0.3) N.S.           N.S. 
Waist Circumference (WC) 91(8)        80(17) 95(11)    95(11) 0.020        0.001 
Hip Circumference (HC) 98(10)     100(13) 104(6)     114(19) N.S.          0.004 
W/Hip Ratio 0.91(0.08)  0.79(0.09) 0.92(0.07)  0.84(0.06) N.S.           N.S. 
Trycipt fold (mm) 9(4)        19(12) 11(7)     26(13) N.S.           N.S. 
Bycipt fold (mm) 5(1)        10(5) 6(4.5)    14(8) N.S.         0.020 
Under-scapula fold (mm) 15(6)        15(10) 17(6)    23(9) N.S.         0.005 
Upper-iliac fold (mm) 16(5)        15(11) 16(5)    30(10) N.S.         0.001 
Fat (kg) 17(4)      22(9) 20(8)    30(10) N.S.         0.004 
FFM (kg) 59(11)     45(5) 63(14)      47(10) N.S.           N.S. 
Food Diary (KCal consumed) 2069(464) 1652(443) 1667(706)  1423(484) N.S.           N.S. 
REE (kcal – Indir. Calorimetry) 1526(283)  1434(224) 1697(514)  1501(527) N.S.           0.033 
REE  (kcal - SW Armband) 1653(366)  1362(246) 1771(461)  1553(259) N.S.           N.S. 
Proteins  (g) 70(24)         61(12) 61(32)       57(16) N.S.           N.S. 
Carbohydrate (simple) (g) 61(70)        74(46) 72(53)        54(21) N.S.           N.S. 
Carbohydrate (complex) (g) 173(84)       166(71) 149(53)      109(49) N.S.           N.S. 
Fat (g) 66(25)        63(18) 58(24)    54(13) N.S.           N.S. 
Cholesterol (Total) (mg) 252(97)       224(95) 223(118)    172(82) N.S.           N.S. 
Saturated Fatty Acid  
(/100 g food g) 20(12)       21(7) 20(13)    18(6) N.S.           N.S. 
MUFA (/100 g food g) 30(10)      30(9) 25(9)    26(5) N.S.           N.S. 
PUFA (/100 g food g) 8(3)          9(3) 8(5)      7(1) N.S.           N.S. 
Fiber (g)       6(3)          7(2)           5(2)       6(2) N.S.           N.S 
Values are expressed as median and interquartile range (IQR) 
 
NAFLD vs C were weight, BMI, waist circumference, DPI, 
insulin serum levels, and consequently HOMA index.  
Median serum triglyceride, ALT and GGT levels were 
significantly higher in patients with NAFLD vs C in males 
only. On the contrary, hip circumference and skinfold 
thickness were found to be significantly higher in females 
with NAFLD, but not in males with NAFLD, which simply 
confirms the “physiological” differences in fat distribution 
between males and females.  No differences were found 
between NAFLD patients and controls in either energy 
expenditure or physical activity, calorie intake and diet 
composition. 
 
4.2. Validation of  REE and PA measurements 
 The agreement between the 3-day physical 
diary and the SWA measurements, expressed in 
metabolic equivalent, of both NAFLD and controls 
patients pooled together (43 men and 29 women) was 
highly significant (p< 0.0001) as calculated using both 
Pearson’s correlation coefficient (r = 0.765; C.I. 0.601-
0.867) and Lin's Concordance Correlation Coefficient 
(data not shown). On the contrary, as shown in Figure 1, 
the level of agreement (LOA) between REE-SWA with 
REE-Vmax, expressed in kcal/day, even when 
significant, was less high in both men and women with 
wide confidential intervals (r= 0.639 with confidence 
interval  0.304-0.679 in males and r= 0.676 with 
confidence interval 0.273-0.673 in females). Figure 2 
shows Lin's Concordance Correlation Coefficient (CCC) 
plots of REE-SWA and REE-Vmax . The fixed bias of 
REE-SWA was 132.42 in males and  85.63 kcal/day in 
females, with high standard deviations, causing wide 
limit of agreement (350 to 521 kcal/day in females and 
292 to 557 kcal/day in males). The Lin's CCC was 
similarly low in both women and men (p<0.0001) 
 
4.3. Univariate and multivariate analysis of predictors 
for NAFLD 
 Tables 2 and 3 give the results of the univariable 
and multivariable analysis of risk factors for NAFLD in 
both sexes. Surprisingly any significant difference was 
found in eating habits, physical activity and REE between 
NAFLD and C. At univariate analysis, increased IR, as 
expressed by both insulinaemia (Figure 3) and the HOMA 
index (Figure 4), increased BMI and waist circumference 
(Figure 5), especially in females, were significant 
predictors of the presence of NAFLD. Interestingly, DPI 
was able to distinguish FL from normal liver, especially in 
males (odd ratio = 29; C.I. 3-295, when DPI > 0.13), and it 
was significantly correlated with the grade of FL in both 
men (Spearman correlation coefficient = 0.594, p<0.0002)
       
 
Figure 1. Levels of agreement (LOA) between Resting 
Energy Expenditure as measured with either a SenseWear 
armband (REE-SWA, in ordinate)  or a Sensor Medics 
Vmax metabolic cart with a ventilated canopy (REE-Vmax, 
in abscissa) in women and men. 
 
       
 
Figure 2. Lin's Concordance Correlation Coefficient 
(CCC) plots between Resting Energy Expenditure as 
measured with either a SenseWear armband (REE-SWA, in 
ordinate)  or a Sensor Medics Vmax metabolic cart with a 
ventilated canopy (REE-Vmax, in abscissa) in women and 
men. 
 
and women (Spearman correlation coefficient = 0.501 
p<0.01), as shown in Figures 6. When all these variables 
significant for the presence of NAFLD at univariate 
analysis were put together and multivariate analysis was 
performed (see Table 3), the only 3 parameters that 
remained statistically significant predictors for the presence 
of NAFLD, as detected by both the likelihood and Wald 
test,  were  DPI greater than 0.13 in males and 0.18 in 
females (p=0.025), waist circumference (WC) greater than 
91 cm in males and 80 cm in females, and a HOMA index 
greater than 0.9 in males and 1.2 in females. When the 
multivariate analysis was applied to each gender, 
interestingly, an altered WC was able to predict the 
presence of FL in females (p Wald <0.030) alone, whereas 
the HOMA index was able to predict FL in males (p Wald 
< 0.004, Table 3) alone. Similarly, when Spearman 
correlation coefficients were calculated, the highest 
correlation coefficients with the grade of FL were waist 
circumference in females (r=0.759, p< 0.000001) and 
insulinaemia  in males (r=0.651, p< 0.0001) (data not 
shown). 
 
5. DISCUSSION 
 
Studies exploring the potential differences 
present in energy expenditure, dietary and lifestyle habits, 
or the correlation of different tools in measuring physical 
activity, and the reliability of the SWA in estimating REE 
as compared with simultaneous indirect calorimetry, in 
patients with NAFLD are lacking (19-23). The present 
study, the first to measure all variables simultaneously, ry 
to cover this lack, in order to design a comprehensive 
picture of habits and conditions associated with NAFLD. 
We evaluated the relationship between IR, anthropometry, 
lifestyle habits, REE and degree of FL at ultrasound in 
NAFLD vs C patients. We found that there were no 
significant differences in eating habits, PA and REE 
between NAFLD and C, although a significant correlation 
was found between waist circumference, HOMA-IR index, 
DPI and grade FL at ultrasound.  
 
The agreement between the 3-day physical diary 
and the SWA measurements, expressed in  metabolic 
equivalent,  in both NAFLD and controls patients, was 
significant, suggesting that SWA is a reliable instrument 
for measuring lifestyle habits, particularly physical activity. 
On the contrary, the agreement between REE-SWA and 
REE-Vmax, even if significant, was not so high in both 
men and women with wide confidential intervals, thus 
confirming the data of Bertoli et al. (20), and suggesting 
that SWA is not an accurate tool for evaluating REE. 
Although the SWA method does not appear to have the 
same accuracy as indirect calorimetry, it could certainly 
have some practical advantages over traditional metabolic 
carts, which are primarily restricted to research laboratories 
and hospitals, because it can be easily used by physicians 
and dieticians, and in many other healthcare settings, both 
in normal subjects, and in patients with NAFLD.  
 
 Although weight and BMI were significantly 
different in the 2 groups studied, NAFLD was not 
associated with a different pattern of dietary intake and
Table 2. Unvaried analysis for the presence of NAFLD 
 TOTAL MALES FEMALES          
 Controls NAFLD 
OR 
(95%C.I.) p Controls NAFLD 
OR 
(95%C.I.) p Controls 
NAFL
D 
OR 
(95%C.I.) p 
BMI  
(>24.9M 
and 
>25.5F) 9/22 (41) 38/46 (83) 7 (2-21) 0,001 4/12 (33) 
22/29 
(76) 6 (1-27) 
0,0
14 5/10 (50) 
16/17 
(94) 16 (1.5-171,2) 0,022 
WC (cm) 
(>91M 
and > 
80F) 9/21 (43) 35/44 (80) 5 (2-16) 0,005 5/11 (45) 
19/27 
(70) 3 (0.7-12) 
0,2
66 4/10 (40%) 
16/17 
(94) 24 (2,2-260,3) 0,009 
Insulin 
(ng/ml) 
(>4M and 
5.3F) 10/21 (48) 31/37 (84) 6 (2-19) 0,006 5/11 (45) 
17/21 
(81) 5 (1-25) 
0,0
56 5/10 (50%) 
14/16 
(87,5) 7 (1-48,3) 0,050 
HOMA 
(>0.9M 
and 1.2F) 8/21 (38) 33/36 (92) 18 (4-78) 0,0001 4/11 (36) 
18/20 
(90) 16 (2-106) 
0,0
03 4/10 (40) 
15/16 
(93,8) 
22,5 (2,1-
244,8) 0,011 
DPI 
(>0.13M 
and 
0.18F) 8/19 (42) 37/42 (88) 10 (3-38) 0,0001 5/11 (45) 
24/25 
(96) 29 (3-295) 
0,0
10 3/8 (37,5) 
13/17 
(76,5) 
5,4 (0,88-
33,4) 0,050 
 
 
 
Figure 3. Correlation between Insulinemia (expressed in 
mU/L in ordinate) and the grade of fatty liver as scored 
with ultrasonography in both men and women. (The values 
of Spearman correlation coefficient  and statistical 
significances are reported within the table).  
 
 
 
Figure 4. Correlation between HOMA index and the grade 
of fatty liver as scored with ultrasonography in both men 
and women. (The values of Spearman correlation 
coefficient  and statistical significances are reported within 
the table).  
 
energy expenditure. This is certainly surprising, since 
weight was remarkably different, however this is not the 
first such finding in literature (33). Very few pilot and non-
controlled studies have demonstrated a close relationship 
between diet and the presence of fatty liver (3, 34-37).  The 
role of either calorie intake or diet composition in 
modulating the presence of fat in the liver is still unclear. 
 
Some authors have shown that NASH patients report a diet 
that is richer in fat, particularly monounsaturated fat, and 
poorer in carbohydrates (34), others (35) that patients with 
NASH had an higher consumption of saturated fat.  Recent 
works suggest that patients with NAFLD have a deficiency 
of n- 3 polyunsaturated fatty acids (n-3 PUFA), and an 
increase in n-6: n-3 fatty acid ratio, which is probably 
related to IR (36), and others authors (37) have 
demonstrated that supplementation with n-3 PUFA in 
patients with NAFLD improves the biochemical, 
ultrasonographic and haemodynamic features of liver 
steatosis. Unlike these preliminary results published by 
other authors (34) (35-37), it hasn’t been found any 
significant differences in eating habits and calorie intake 
between NAFLD and controls, however, this could simply 
suggest that the tests routinely used, such as the 7-day diary 
or the semi-quantitative illustrated food questionnaire, are 
too insensitive to measure small changes in dietary intake.  
 
Furthermore, physical activity and REE seem to 
be similar, thus suggesting that the only evident effect is 
metabolic. NAFLD is considered the hepatic component of 
metabolic syndrome, and lifestyle modifications, including 
increased physical activity, is definitely useful, and 
possibly more useful than pharmacological interventions to 
avoid progression of this disease(3). Only recently, Zelber-
Sagi et al., in a larger cohort of patients, demonstrated that 
habitual leisure-time physical activity, especially anaerobic, 
may play a protective role in reducing abdominal obesity in 
NAFLD (4). However, the difference found in previous 
studies was minimal and their cohort was larger than the 
cohort of this study. The few studies available thus far do 
not allow causal inference between reduced physical 
activity and the presence of fatty liver, since it is also 
possible that NAFLD patients tend to be less physically 
active because of their obesity-associated disorders.  
 
 In this study, the only parameters found to be 
significant predictors of NAFLD at univariate analysis in 
both sexes, were all inter-related: weight, BMI, waist 
circumference, DPI, and IR.  Interestingly, DPI was 
significantly correlated with the grade of fatty liver in both 
sexes. This confirms that, when correctly assessed, DPI 
could be used as a reliable indirect measurement to 
quantify the amount of hepatic fat content (29, 37). At
   Table 3. Multivariate analysis of risk factors for the presence of NAFLD 
 TOTAL 
Controls vs NAFLD 
(p- wald) 
TOTAL 
Controls vs 
NAFLD (p- LR) 
MALES 
Controls vs 
NAFLD (p- wald)
 
MALES 
Controls vs NAFLD 
(p- LR) 
FEMALES 
Controls vs NAFLD 
(p- wald) 
 
FEMALES 
Controls vs 
NAFLD (p- LR) 
 
BMI 
(24.9M and 25.5F) 
0.589* 0.525* 0.300* 0.300* 0.302* 0.386* 
WC (cm) 
(>91M and > 80F) 
0.021 0.003 0.185* 0.185* 0.030 0.001 
Insulin (ng/ml) 
(>4M and 5.3F) 
0.171* 0.089* 0.384* 0.384* 0.854* 0.096* 
HOMA 
(>0.9M and 1.2F) 
0.008 0.001 0.050 0.004 0.087* 0.006 
DPI 
(>0.13M and 0.18F) 
0.025 0.025 0.269* 0.269* 0.120* 0.090* 
   *in the stepwise analysis they were taken out of the model  
 
 
Figure 5. Correlation between WC (expressed in cm in ordinate)  and the grade of fatty liver as scored with ultrasonography in 
both men and women. (The values of Spearman correlation coefficient  and statistical significances are reported within the table).  
 
 
 
Figure 6. Correlation between Doppler Power Index (DPI) and the grade of fatty liver as scored with ultrasonography in both 
men and women. (The values of Spearman correlation coefficient  and statistical significances are reported within the table).  
 
multivariate analysis, the only 3 parameters that remained 
significant predictors for the presence of NAFLD, were 
DPI in both sexes (> 0.13 in men and > 0.18 in women), 
WC in females (> 80 cm), and the HOMA index in males 
(> 0.9), suggesting that the presence of  IR is better 
predicted by measuring waist circumference in females, 
and the HOMA index in males. 
We may conclude that, in a short series of 
consecutive asymptomatic overweight patients referred to 
our Liver Centre outpatient facility, SWA could be used as 
a simple, valid and practical instrument to measure lifestyle 
habits in patients with NAFLD. This study also suggest that 
there is strong evidence of a significant association between 
the presence of NAFLD, central adiposity and IR, as 
measured by waist circumference and the HOMA index, 
and that by calculating DPI during hepatic ultrasound, it is 
possible to obtain a sensitive measurement of the amount of 
fat present within the liver. However more and, larger 
studies are needed to validate these results.  
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